Minimally invasive surgery for deep brain bleeds
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests whether a minimally invasive surgery can safely remove a deep brain bleed (intracerebral hemorrhage) to improve recovery. It aims to see if this gentler approach helps people with moderate-sized bleeds do better than standard care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have had a spontaneous bleed deep in the brain (in the basal ganglia area), confirmed by a CT scan.
- The bleed is moderate in size (about 30–80 mL, roughly 2–5 tablespoons).
- You can start treatment within 72 hours of when symptoms began.
- You are not in a coma and have some awareness (Glasgow Coma Scale score 5–14).
- You were able to function independently before this bleed (modified Rankin Scale score 0–1).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a less invasive surgery to remove small blood clots (20–30 ml) in the basal ganglia, a deep part of the brain. It may help people who are awake but have a reduced level of consciousness after a recent brain bleed.
This trial tests if a minimally invasive surgery guided by a robotic AI system can help people with moderate bleeding deep inside the brain (basal ganglia). If you qualify, the surgery would happen within 72 hours of your stroke.
This trial tests a minimally invasive surgery (soft channel drainage) to remove a large blood clot deep in the brain after a stroke. It is for people who can have the procedure within 48 hours of bleeding and whose consciousness is reduced but not completely gone.
This study tracks patients who have had sudden, severe bleeding in the brain and received minimally invasive surgery (a less-invasive surgical approach) to treat it. Researchers want to understand outcomes and improve treatment for this serious condition.
This study tests a combination of a minimally invasive surgery to remove the brain bleed and a medication called deferoxamine (which may help reduce damage from the bleed). The goal is to see if this combination helps improve recovery after a brain hemorrhage.
This trial tests a minimally invasive surgery to remove blood clots deep in the brain after a spontaneous bleed. It may help patients with moderate to large bleeds who are at least 18 and up to 80 years old.
Hear when a new Intracerebral Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.